Company Showcase

Sandoz B2B and Business Development


Active Pharmaceutical Ingredients


Contract Manufacturing


Finished Dosage Forms in-licensing

Posted By

Ashish Menocha

Vice President Global Partnerships & Strategy, B2B

[email protected]

David Tonin

Head Global Sales

[email protected]

Ben Toogood

Head Global BD and M&A

[email protected]

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2019 sales of USD 9.7 billion.

Related Categories

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

31 August - 2 September 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info